Clinical Trial Update: Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cyclophosphamide, rituximab, and prednisone or methylprednisolone for lymphoproliferative disease after solid organ transplantation; co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoproliferative Disorder

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• METHYLPREDNISOLONE (methylprednisolone)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)

Snippet

Sponsor: Children's Oncology Group | Conditions: Lymphoproliferative Disorder | Phase 2 | Status: COMPLETED | Results posted: 2014-01-17